An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study. (2021)

First Author: Surey J
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12879-021-05766-9

PubMed Identifier: 33478428

Publication URI: http://europepmc.org/abstract/MED/33478428

Type: Journal Article/Review

Volume: 21

Parent Publication: BMC infectious diseases

Issue: 1

ISSN: 1471-2334